Post by Parexel

Name: Why do some cell and gene therapy (CGT) programs succeed while others stall? The path to successfu
Uploaded: 2026-06-05T13:42:09.194Z
Channel: Parexel
Description: Why do some cell and gene therapy (CGT) programs succeed while others stall? The path to successful CGT development isn't always about moving to the next asset — it's about asking the right question

895,708 followers

Why do some cell and gene therapy (CGT) programs succeed while others stall? The path to successful CGT development isn't always about moving to the next asset — it's about asking the right questions about the current one. In a new article in Drug Discovery and Development, Chris A. Learn, PhD, MBA, PMP explores four critical factors that can define clinical outcomes: 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲, 𝗱𝗼𝘀𝗲, 𝗿𝗼𝘂𝘁𝗲 𝗮𝗻𝗱 𝗮𝗱𝗺𝗶𝗻𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻. "These distinctions are not variables to be optimized after the science is settled — they are the science." Read the full piece on why delivery strategy is a core capability, not an operational detail. 👉 https://lnkd.in/dpSZecGJ

Video Content